In the last few years, biotech companies in Korea have targeted innovation in drug development and are building platform...
Singapore: German drug major Boehringer Ingelheim has planned to build a biologics plant in Shanghai, China, to offer co...
Singapore: Researchers at Singapore's Institute of Bioengineering and Nanotechnology (IBN) and California's IBM Research...
Singapore: Novartis highlighted that the results of a global phase III study showed that Afinitor (everolimus) did not e...
Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, submitted a pre-Investigational New Drug (...
Singapore: Australian drug delivery company, Phosphagenics, has raised $19.3 million via a placement of $16.3 million to...
Singapore, July 09, 2012: Bayer HealthCare has started to enroll patients in an international Phase II/III trial to eval...
Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 m...
Singapore: Astellas Pharma signed a license agreement with Janssen Biotech under which Janssen has an exclusive right to...
Singapore: Eisai announced that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory C...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem has received notice of Allowanc...
Minoryx Therapeutics, a drug development company specialized in the discovery and development of new drugs for orphan di...
Apollo Therapeutics, the collaborative venture between three world-leading UK universities and three global pharmaceutic...
US based Pelical BioThermal which is a global leader providing the broadcast and most innovative range of temperature-co...
Singapore: The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, an...
